"Innovation... Continuous Improvement... Customer Focus..."
If these words resonate with you, Anika Therapeutics is the place to be. Our focus is on what’s ahead, not what we have already done. There are new frontiers to be explored, new discoveries to be made, new treatments to be developed.
Our employees are bright, energetic individuals who share a common goal and a spirit of teamwork. From Product Development, to Technology Transfer and Production, each individual adds value and our success is as a whole.
Individuals who are successful at Anika Therapeutics have a “can do” attitude, can think both inside and outside the box, and believe product quality starts with the first glimmer of an idea in the product development stage.
Explore our Careers section further to see how you fit the Anika Team.
In The News...
The Boston Globe recently published
the 24th annual Globe 100 list
which ranked Anika Therapeutics
as one of the top performing
Massachusetts public companies.
The rankings are based on how
well the companies increased
sales, profits and returns for
shareholders during 2011.
In order to be considered for the Globe 100 a company must: maintain a headquarters in Massachusetts, trade its shares on the New York Stock Exchange, the NASDAQ Stock Market, or the NYSE Amex, have been a public company for all of 2011, and report revenue and profit for both 2010 and 2011. Rankings are based on four financial factors calculated for the 2011 calendar year: Return on average equity; one-year change in revenue; one-year change in profit margin; and 2011 revenue.
As well as being ranked in the Globe 100, Anika was also ranked in the Growth 50. We were number 6 this year, rising from our number 17 spot last year. In order to be considered for the Growth 50, a company must have been publicly traded for two full years and must have reported profits during all periods.